FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2982142950> ?p ?o ?g. }

• W2982142950 abstract "Nicotinic acetylcholine receptors (nAChRs) have been reported to be overexpressed in malignancies in humans and is associated with tumorigenesis and cell migration. In previous studies of gastric cancer, alpha7 nicotinic acetylcholine receptor (α7-nAChR) overexpression leads to epithelial-mesenchymal transition (EMT) and promotes the migration of gastric cancer cells. Recombinant avirulent LaSota strain of Newcastle disease virus (NDV) expressing the rabies virus glycoprotein (rL-RVG) may promote apoptosis of gastric cancer cells and reduces the migration of lung cancer metastasis. However, whether rL-RVG inhibits migration of gastric cancer cells and what the underlying functional mechanism is remains unknown.The gastric cancer cell lines BGC and SGC were randomly divided into 3 groups: rL-RVG, NDV and Phosphate Buffered Solution (PBS) control groups. Furthermore,we adopted ACB and MLA,α7nAChR-siRNA for the overexpression and silencing of α7-nAChR.Corynoxenine was used for inhibiting the MEK-ERK pathway. Western blot, Immunofluoresce,cell proliferation assays,cell migration analyses through wound-healing assays and Transwell assays were used to explore the underlying mechanisms. A mouse xenograft model was used to investigate the effects of rL-RVG,NDV on tumor growth.In this study, our findings demonstrate that rL-RVG suppressed the migration of gastric cancer cells and reduced EMT via α7-nAChR in vitro. Furthermore rL-RVG decreased the phosphorylation levels of the MEK/ERK signaling pathway such as down-regulating the expression of P-MEK and P-ERK. Additionally, rL-RVG also reduced the expression level of mesenchymal markers N-cadherin and Vimentin and enhanced the expression of the epithelial marker E-cadherin. Lastly, rL-RVG inhibited nicotinic acetylcholine receptors (nAChRs) to suppress cell migration and epithelial to mesenchymal transition (EMT) in gastric cell. We also found that rL-RVG suppresses the growth of gastric cancer subcutaneous tumor cells in vivo.rL-RVG inhibits α7-nAChR-MEK/ERK-EMT to suppress migration of gastric cancer cells." @default.
• W2982142950 created "2019-11-01" @default.
• W2982142950 creator A5005827766 @default.
• W2982142950 creator A5006483303 @default.
• W2982142950 creator A5012560609 @default.
• W2982142950 creator A5024387391 @default.
• W2982142950 creator A5031150824 @default.
• W2982142950 creator A5063622904 @default.
• W2982142950 creator A5073440190 @default.
• W2982142950 creator A5073501391 @default.
• W2982142950 creator A5083375915 @default.
• W2982142950 date "2019-10-22" @default.
• W2982142950 modified "2023-10-15" @default.
• W2982142950 title "Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating α7-nicotinic acetylcholine receptors/ERK- EMT" @default.
• W2982142950 cites W1547736903 @default.
• W2982142950 cites W1550319538 @default.
• W2982142950 cites W1587262318 @default.
• W2982142950 cites W1594018550 @default.
• W2982142950 cites W1960864063 @default.
• W2982142950 cites W1979757857 @default.
• W2982142950 cites W1996130952 @default.
• W2982142950 cites W2004164502 @default.
• W2982142950 cites W2033927159 @default.
• W2982142950 cites W2053566746 @default.
• W2982142950 cites W2065455574 @default.
• W2982142950 cites W2075323804 @default.
• W2982142950 cites W2078204613 @default.
• W2982142950 cites W2162402991 @default.
• W2982142950 cites W2272984102 @default.
• W2982142950 cites W2416874871 @default.
• W2982142950 cites W2419214530 @default.
• W2982142950 cites W2463191693 @default.
• W2982142950 cites W2473734562 @default.
• W2982142950 cites W2581145348 @default.
• W2982142950 cites W2763033244 @default.
• W2982142950 cites W2772955446 @default.
• W2982142950 cites W2789359169 @default.
• W2982142950 cites W2861975976 @default.
• W2982142950 cites W2888833421 @default.
• W2982142950 cites W2889069320 @default.
• W2982142950 cites W2889646458 @default.
• W2982142950 cites W2890074591 @default.
• W2982142950 cites W2893750311 @default.
• W2982142950 cites W2899780962 @default.
• W2982142950 cites W2900341474 @default.
• W2982142950 cites W562149274 @default.
• W2982142950 doi "https://doi.org/10.1186/s12885-019-6225-9" @default.
• W2982142950 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6805660" @default.
• W2982142950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31640627" @default.
• W2982142950 hasPublicationYear "2019" @default.
• W2982142950 type Work @default.
• W2982142950 sameAs 2982142950 @default.
• W2982142950 citedByCount "12" @default.
• W2982142950 countsByYear W29821429502020 @default.
• W2982142950 countsByYear W29821429502021 @default.
• W2982142950 countsByYear W29821429502022 @default.
• W2982142950 countsByYear W29821429502023 @default.
• W2982142950 crossrefType "journal-article" @default.
• W2982142950 hasAuthorship W2982142950A5005827766 @default.
• W2982142950 hasAuthorship W2982142950A5006483303 @default.
• W2982142950 hasAuthorship W2982142950A5012560609 @default.
• W2982142950 hasAuthorship W2982142950A5024387391 @default.
• W2982142950 hasAuthorship W2982142950A5031150824 @default.
• W2982142950 hasAuthorship W2982142950A5063622904 @default.
• W2982142950 hasAuthorship W2982142950A5073440190 @default.
• W2982142950 hasAuthorship W2982142950A5073501391 @default.
• W2982142950 hasAuthorship W2982142950A5083375915 @default.
• W2982142950 hasBestOaLocation W29821429501 @default.
• W2982142950 hasConcept C121608353 @default.
• W2982142950 hasConcept C126322002 @default.
• W2982142950 hasConcept C137738243 @default.
• W2982142950 hasConcept C203014093 @default.
• W2982142950 hasConcept C2779013556 @default.
• W2982142950 hasConcept C2780210213 @default.
• W2982142950 hasConcept C502942594 @default.
• W2982142950 hasConcept C54355233 @default.
• W2982142950 hasConcept C57074206 @default.
• W2982142950 hasConcept C62478195 @default.
• W2982142950 hasConcept C71924100 @default.
• W2982142950 hasConcept C81885089 @default.
• W2982142950 hasConcept C86803240 @default.
• W2982142950 hasConcept C95444343 @default.
• W2982142950 hasConcept C96232424 @default.
• W2982142950 hasConceptScore W2982142950C121608353 @default.
• W2982142950 hasConceptScore W2982142950C126322002 @default.
• W2982142950 hasConceptScore W2982142950C137738243 @default.
• W2982142950 hasConceptScore W2982142950C203014093 @default.
• W2982142950 hasConceptScore W2982142950C2779013556 @default.
• W2982142950 hasConceptScore W2982142950C2780210213 @default.
• W2982142950 hasConceptScore W2982142950C502942594 @default.
• W2982142950 hasConceptScore W2982142950C54355233 @default.
• W2982142950 hasConceptScore W2982142950C57074206 @default.
• W2982142950 hasConceptScore W2982142950C62478195 @default.
• W2982142950 hasConceptScore W2982142950C71924100 @default.
• W2982142950 hasConceptScore W2982142950C81885089 @default.
• W2982142950 hasConceptScore W2982142950C86803240 @default.
• W2982142950 hasConceptScore W2982142950C95444343 @default.
• W2982142950 hasConceptScore W2982142950C96232424 @default.
• W2982142950 hasFunder F4320321001 @default.
• W2982142950 hasIssue "1" @default.

• next